|•||How to use immunopeptidomics to study antigen presentation of MHC molecules|
|•||Understand how artificial intelligence helps dig deeper into immunopeptidomics mass spectrometry data to identify tumor antigens|
|•||Understand how implementing quantitative mass spectrometry-based approaches can identify treatment-modulated tumor antigens as targets for immunotherapy|
Dr. Lauren Stopfer
Lauren earned a B.S. from the University of Wisconsin-Madison and Ph.D. from the Massachusetts Institute of Technology studying phosphoproteomics, immunopeptidomics, and systems biology. She is currently a scientist on the Proteomics team at BioNTech US, where she focuses on applying proteomics and immunopeptidomics methodologies to oncology and infectious disease applications.